Radio Cadena Agramonte emisiora de Camagüey
Havana, 1st. Feb.- Obtaining innovative products, expanding the country's therapeutic arsenal, working together with universities and exporting goods and services become results of the Center for Research and Development of Medicines (CIDEM in Sapnish), in its 30 years of work for the benefit of health human.
Maray Pons, communications specialist, told ACN about the entity's participation in more than 600 projects linked to national and sectoral programs of social impact, among which the generalization of natural and traditional medicine, medicines for cancer and AIDS, stand out. and ophthalmological products used in “Operation Miracle.”
He highlighted the contributions of CIDEM, with more than 500 drugs, to the configuration of the Basic Array of Medicines and scientific activity during these three decades, supported by twenty national awards from the Cuban Academy of Sciences and several for Technological Innovation and Specialties. of Relevance, awarded by CITMA, and articles published in high-level Cuban and foreign magazines.
In line with trends in the biotechnology and pharmaceutical industry, CIDEM, belonging to the BioCubaFarma business group, has five lines of research-development of innovative, generic, natural, health-related and diagnostic products, and its closed-loop operation favors the transfer of technologies to the industry.
Pons pointed out as an important element the alliances they maintain with the academic and business sector in Cuba and other nations, and exemplified the inauguration in 2018, together with the University of Havana, of the chemical and biomolecular synthesis laboratory, with the aim of promote the management of innovation projects in the area of ??medicines.
CIDEM entered the international market with the portfolio of natural products and seeks to awaken new commercial interests, thanks to business models based on cooperative productions, technology transfers and licensing of co-development of projects, among other modalities.
In the effort to expand its scope for the benefit of health and the Cuban economy, this company provides specialized services to entities in the country and in various latitudes such as oncological and toxicological research, experimental neuropharmacology and research and development of antimicrobials, he pointed out.
According to Pons, the valuable contributions of this institution would be impossible without the motivation and commitment of its workers, who ratified their responsibility to the nation during the covid-19 pandemic by assuming the processing of more than 120 thousand PCR samples in time. real and toxicological studies of the Abdala vaccine and in the Soberana clinical trial in pediatrics.
Founded on January 31, 1994 by Commander in Chief Fidel Castro, CIDEM's work in defense of human health in Cuba and the world confirms the value of the historic leader's commitment to promoting the country's biotechnology and pharmaceutical sector, even in very complex economic conditions. (ACN) (Photo: Facebook page of the Center for Drug Research and Development)
